The creation of retatrutide, a novel dual stimulant targeting both GLP-1 and GIP receptors, involves a complex several-stage synthetic process. Initial routes focused on protein fragment coupling, utilizing solid-phase synthesis methodologies to build the long protein sequence. Subsequent investigation has explored different approaches, includin… Read More